{"name": "Cerephex",
 "permalink": "cerephex",
 "crunchbase_url": "http://www.crunchbase.com/company/cerephex",
 "homepage_url": "http://www.cerephex.com",
 "blog_url": "",
 "blog_feed_url": "http://www.cerephex.com/News.html",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Sat Oct 13 09:55:09 UTC 2012",
 "updated_at": "Sat Apr 27 13:53:57 UTC 2013",
 "overview": "\u003Cp\u003ECerephex is a company developing its proprietary RINCE technology for  treatment applications involving noninvasive  brain stimulation.  Cerephex is currently  engaged in development activities aimed at gaining  FDA approval  of its NeuroPoint device for  the management of  fibromyalgia, a chronic pain condition that involves abnormal central pain \nprocessing mechanisms. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0021/5406/215406v1-max-150x150.jpg"],
     [[243,
       78],
      "assets/images/resized/0021/5406/215406v1-max-250x250.jpg"],
     [[243,
       78],
      "assets/images/resized/0021/5406/215406v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder, CEO",
    "person":
     {"first_name": "Rob",
      "last_name": "Ford",
      "permalink": "rob-ford",
      "image": null}},
   {"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Bill",
      "last_name": "Mavity",
      "permalink": "bill-mavity",
      "image": null}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "R.",
      "last_name": "Michael Gendreau",
      "permalink": "r-michael-gendreau",
      "image": null}},
   {"is_past": false,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Jeff",
      "last_name": "Hargrove",
      "permalink": "jeff-hargrove",
      "image": null}},
   {"is_past": false,
    "title": "VP Business Development",
    "person":
     {"first_name": "Buck",
      "last_name": "Beranek",
      "permalink": "buck-beranek",
      "image": null}},
   {"is_past": false,
    "title": "Chief Financial Officer",
    "person":
     {"first_name": "Deryl",
      "last_name": "Banks",
      "permalink": "deryl-banks",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020121012e8acnt2jc\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020121012e8acnt2jc%26from%3dalert%26pid%3d32",
    "source_description": "Neurostim Device Maker Cerephex Raises Series A Tranche for Trials",
    "raised_amount": null,
    "raised_currency_code": null,
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "H.I.G. BioVentures",
         "permalink": "h-i-g-bioventures",
         "image":
          {"available_sizes":
            [[[136,
               72],
              "assets/images/resized/0025/9378/259378v1-max-150x150.png"],
             [[136,
               72],
              "assets/images/resized/0025/9378/259378v1-max-250x250.png"],
             [[136,
               72],
              "assets/images/resized/0025/9378/259378v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "CHV Ventures",
         "permalink": "chv-ventures",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "231 Mary Alice Drive Los Gatos, CA 95032",
    "address2": "",
    "zip_code": "",
    "city": "",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        99],
       "assets/images/resized/0021/5407/215407v1-max-150x150.jpg"],
      [[250,
        166],
       "assets/images/resized/0021/5407/215407v1-max-250x250.jpg"],
      [[450,
        299],
       "assets/images/resized/0021/5407/215407v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}